U.S. FDA Extends Review Timeline for INVOKANA® (canagliflozin) Supplemental New Drug Application
The Janssen Pharmaceutical Companies of...
Read MoreThe Janssen Pharmaceutical Companies of...
Read MoreThe Institut Pasteur officially unveiled...
Read MoreVirus-like particles (VLPs) are protein-based...
Read MoreAmgen (NASDAQ:AMGN) and UCB (Euronext...
Read MoreBruker Corporation today announced that...
Read MoreExpanding its footprint in India,...
Read MoreVeterans with cancer who receive...
Read MoreSRI International today announced a...
Read More